This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:protocol:olmesartan:kidney_disease [10.19.2018] – [Notes and comments] sallieq | home:protocol:olmesartan:kidney_disease [05.09.2019] – [Elevated kidney values tend to be temporary] sallieq | ||
---|---|---|---|
Line 45: | Line 45: | ||
// | // | ||
+ | |||
+ | " | ||
===== Benefits of olmesartan for patients with kidney disease ===== | ===== Benefits of olmesartan for patients with kidney disease ===== | ||
Line 55: | Line 57: | ||
MP patients with kidney inflammation and their healthcare practitioners should be extremely comforted by the fact that the patient is taking olmesartan. This is due to the great number of studies, which have found that olmesartan and other ARBs protect the kidneys from the effects of inflammation and cytokine damage. | MP patients with kidney inflammation and their healthcare practitioners should be extremely comforted by the fact that the patient is taking olmesartan. This is due to the great number of studies, which have found that olmesartan and other ARBs protect the kidneys from the effects of inflammation and cytokine damage. | ||
- | The benefits of olmesartan on patients with kidney inflammation include: | + | The benefits of olmesartan on patients with kidney inflammation include |
* decreased insulin resistance, fewer symptoms of the metabolic syndrome, and decreased inflammation in patients with chronic kidney disease.(({{pubmed> | * decreased insulin resistance, fewer symptoms of the metabolic syndrome, and decreased inflammation in patients with chronic kidney disease.(({{pubmed> | ||
Line 84: | Line 86: | ||
Olmesartan also has [[home: | Olmesartan also has [[home: | ||
- | {{tag> | + | {{tag> |
==== Animal studies ==== | ==== Animal studies ==== | ||
Line 93: | Line 95: | ||
Ability of Olmesartan to ameliorate renal injury and fibrosis in rats when taken at ultrahigh doses.(({{pubmed> | Ability of Olmesartan to ameliorate renal injury and fibrosis in rats when taken at ultrahigh doses.(({{pubmed> | ||
- | {{tag> | + | {{tag> |
===== Notes and comments ===== | ===== Notes and comments ===== | ||
+ | |||
+ | Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate < | ||